Remove topic ingredients
article thumbnail

Rapid pseudomonas aeruginosa detection method developed

European Pharmaceutical Review

In the paper, the author acknowledged that topical medicinal products require the absence of bacterial species such as P. Optimising microbial detection The paper proposed a new culture medium that includes all optimal ingredients for the detection of P. aeruginosa. aeruginosa bacteria within six hours” Individual P.

Media 92
article thumbnail

Eyenovia and Formosa partner for new ophthalmic therapeutics

Pharmaceutical Technology

The collaboration will combine the Optejet dispensing technology of Eyenovia with the APNT nanoparticle formulation platform of Formosa to develop topical therapeutics. Formosa’s APNT platform reduces the particle size of the active pharmaceutical ingredient. It reduces the overdosing and unnecessary drug exposure risk.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Importance of Semantic Search Capabilities for Life Sciences Orgs

Copyright Clearance Center

Semantic enrichment is the ingredient behind getting relevant search results even if they don’t use the same terminology as the query. This is where functionality beyond linking key terms evolves into topic-linking (or topic co-occurrence).

article thumbnail

Oculis SA and EBAC join to drive ophthalmology innovation

pharmaphorum

It combines dexamethasone, an approved active ingredient proven as effective and safe in the treatment of DME, with Oculis’ novel formulation Optireach technology, which facilitates active ingredient access to the back of the eye. glaucoma), the OCS-05 proof-of-concept trial in acute optic neuritis.

article thumbnail

QA of prostaglandin analogues for glaucoma treatment

European Pharmaceutical Review

The paper suggested low bioavailability after topical ophthalmic administration is evidence of the need for more effective molecules, as well as formulations that target sites more precisely. A key challenge discussed is active pharmaceutical ingredient (API) impurity profiling in finished dosage forms.

article thumbnail

Futura eyes FDA filing as topical ED drug passes phase 3 test

pharmaphorum

Futura Medical’s development of a topical treatment for erectile dysfunction (ED) is approaching the finish line in the US, as the UK biotech reports confirmatory phase 3 data ahead of an FDA filing later this month. ” The post Futura eyes FDA filing as topical ED drug passes phase 3 test appeared first on.

FDA 52
article thumbnail

Improving end-to-end customer experience with Clarivate: being prepared

Clarivate

By being prepared, you demonstrate that you care about the people involved and the topic. Three ingredients for success. Being responsive , treating everyone as your customer and being prepared are the key ingredients to a successful CX program. Being prepared. You demonstrate respect.